Literature DB >> 5016236

Mechanism of complement action in rosette inhibition and lymphocytotoxicity of antilymphocyte serum.

J F Bach, I Gigli, M Dardenne, J Dormont.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 5016236      PMCID: PMC1407844     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  23 in total

1.  ACTION OF THE FIRST COMPONENT OF COMPLEMENT. ACTIVITATION OF C'1 TO C'1A IN THE HEMOLYTIC SYSTEM.

Authors:  T BORSOS; H J RAPP; U L WALZ
Journal:  J Immunol       Date:  1964-01       Impact factor: 5.422

2.  Neutralization of sensitized virus by purified components of complement.

Authors:  C A Daniels; T Borsos; H J Rapp; R Snyderman; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1970-03       Impact factor: 11.205

Review 3.  The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives.

Authors:  E M Lance
Journal:  Clin Exp Immunol       Date:  1970-06       Impact factor: 4.330

4.  [Analytic study of 69 anti-mouse lymphocyte rabbit serums. I. "In vivo" activity].

Authors:  J F Bach; M Dardenne; P Galanaud; J M Watchi; B Antoine
Journal:  Pathol Biol (Paris)       Date:  1970-05

5.  In vitro rosette inhibition by antihuman antilymphocyte serum. Correlation with skin graft prolongation in subhuman primates.

Authors:  J F Bach; J Dormont; M Dardenne; H Balner
Journal:  Transplantation       Date:  1969-09       Impact factor: 4.939

6.  A new in vitro test evaluating anti-lymphocyte serum potency.

Authors:  J F Bach; M Dardenne; J Dormont; B Antoine
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

7.  Activation of C'1 to C'1 esterase on gel filtration on Sephadex G-200. Studies on normal human serum, euglobulin and hereditary angioneurotic edema serum.

Authors:  A B Laurell; R Siboo
Journal:  Acta Pathol Microbiol Scand       Date:  1966

8.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

9.  Immunosuppressive and graft-rejecting anti--bodies in heterologous anti-lymphocytic serum.

Authors:  B Cinader; H F Jeejeebhoy; S W Koh; A G Rabbat
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

10.  ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

Authors:  U R NILSSON; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

View more
  3 in total

1.  In vitro culture of functional human thymic epithelium.

Authors:  M Papiernik; B Nabarra; J F Bach
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

Review 2.  The pharmacological and immunological basis for the use of immunosuppressive drugs.

Authors:  J F Bach
Journal:  Drugs       Date:  1976       Impact factor: 9.546

3.  Effect of generalized graft-versus-host-reaction on B- and T-lymphocytes and a benzpyrene-induced murine sarcoma.

Authors:  C Witting; E Hultsch
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-10-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.